Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Immunogen
Immunogen
(IMGN)
ImmunoGen, Inc. (Nasdaq: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Elahere
Mirvetuximab soravtansine
2022-11-14
Fallopian tube neoplasms
,
Ovarian epithelial carcinoma
,
Peritoneal neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mirvetuximab soravtansine
neoplasms
,
carcinosarcoma
,
hereditary breast and ovarian cancer syndrome
,
endometrial neoplasms
,
endometrioid carcinoma
,
acinar cell carcinoma
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
ovarian neoplasms
,
peritoneal neoplasms
Rucaparib
prostatic neoplasms
Rucaparib camsylate
prostatic neoplasms
Etrolizumab
leukemia
,
myeloid leukemia acute
,
neoplasms
,
myeloid leukemia
Doconexent
ulcerative colitis
,
colitis
,
ulcer
ANETUMAB RAVTANSINE
non-small-cell lung carcinoma
,
medical sociology
,
ovarian neoplasms
,
triple negative breast neoplasms
,
cholangiocarcinoma
,
thymoma
,
renal insufficiency
,
oncogenes
,
neoplasms
,
lung neoplasms
,
pancreatic neoplasms
,
mesothelioma
,
malignant mesothelioma
,
endometrioid carcinoma
,
adenocarcinoma
,
adenocarcinoma of lung
Bevifimod
clostridium infections
CANTUZUMAB RAVTANSINE
colorectal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
Doxecitine
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
pharyngeal neoplasms
,
peritoneal neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
,
neoplasms
,
adenocarcinoma
,
pancreatic ductal carcinoma
,
rectal neoplasms
,
esophageal neoplasms
,
small cell lung carcinoma
,
liver neoplasms
,
ovarian epithelial carcinoma
,
brain neoplasms
,
urologic neoplasms
,
non-muscle invasive bladder neoplasms
,
castration-resistant prostatic neoplasms
,
endometrial neoplasms
,
hepatocellular carcinoma
,
adenocarcinoma of lung
,
renal cell carcinoma
,
prostatic neoplasms
,
sarcoma
,
breast neoplasms
,
biliary tract neoplasms
,
urinary bladder neoplasms
,
neoplasm metastasis
,
cholangiocarcinoma
,
colorectal neoplasms
,
carcinoma
,
lung neoplasms
,
ovarian neoplasms
,
esophageal squamous cell carcinoma
,
gallbladder neoplasms
,
transitional cell carcinoma
,
fallopian tube neoplasms
,
bile duct neoplasms
,
endometrioid carcinoma
,
mucinous cystadenocarcinoma
,
acinar cell carcinoma
,
unknown primary neoplasms
,
klatskin tumor
,
non-small-cell lung carcinoma
LORVOTUZUMAB MERTANSINE
multiple myeloma
,
recurrence
,
ovarian neoplasms
,
merkel cell carcinoma
,
plasma cell neoplasms
,
lung neoplasms
,
small cell lung carcinoma
,
neuroblastoma
,
synovial sarcoma
,
rhabdomyosarcoma
,
neurofibrosarcoma
,
wilms tumor
,
pulmonary blastoma
,
leukemia
,
hematologic neoplasms
Lotamilast
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
hypertension
,
hepatitis c
,
hepatitis
,
hepatitis a
,
neoplasms
,
overactive urinary bladder
,
parkinson disease
,
central nervous system diseases
,
brain diseases
,
movement disorders
,
neurodegenerative diseases
,
head and neck neoplasms
,
cough
,
schizophrenia
,
nervous system diseases
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
leukemia
,
myelodysplastic syndromes
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
blast crisis
,
lymphoid leukemia
,
melanoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
panic disorder
,
alcoholism
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
general anesthesia
,
glioblastoma
,
astrocytoma
,
anesthesia
,
muscle relaxation
,
delayed emergence from anesthesia
NARATUXIMAB EMTANSINE
leukemia
,
non-hodgkin lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
Polyglycolic acid
ovarian neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
Remetinostat
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
hypertension
,
hepatitis c
,
hepatitis
,
hepatitis a
,
neoplasms
,
overactive urinary bladder
,
parkinson disease
,
central nervous system diseases
,
brain diseases
,
movement disorders
,
neurodegenerative diseases
,
head and neck neoplasms
,
cough
,
schizophrenia
,
nervous system diseases
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
leukemia
,
myelodysplastic syndromes
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
blast crisis
,
lymphoid leukemia
,
melanoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
panic disorder
,
alcoholism
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
general anesthesia
,
glioblastoma
,
astrocytoma
,
anesthesia
,
muscle relaxation
,
delayed emergence from anesthesia
Usistapide
laparoscopy
,
myocardial infarction
,
coronary artery disease
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use